Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Microbot Medical Inc.NASDAQ: MBOT
Short-term Investments · Q1 FY2026 · quarter ended Mar 2026
Short-term investments rises 153.4% from a year ago
Short-term investments stood at $68.84M at the end of Q1 FY2026, up 153.4% from a year earlier and down 7.8% from the prior quarter. Over 3 fiscal years it compounded at +134.9% a year.
Context
- Short-term investments amounted to 88.2% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Short-term investments increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term investments keeps rising in the next quarterly balance sheet after a +153.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 74.68M USD
- Year-over-year change
- +3069.8%
- 4-year CAGR
- +147.2%
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 74.68M | +3069.8% |
| FY2024 | 2024-12-31 | 2.36M | -39.9% |
| FY2023 | 2023-12-31 | 3.92M | -32.0% |
| FY2022 | 2022-12-31 | 5.76M | +188.1% |
| FY2021 | 2021-12-31 | 2M | — |
Short-term Investments vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +153.4% is the 2nd highest of 4, against a peer median of -6.2%.
- Short-term investments amounts to 88.2% of total assets for MBOT, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $68.84M USD | +153.4% | +134.9% | 88.2% | |
| Mar 2026 | $61.46M USD | +181.1% | -12.4% | 27.2% | |
| Mar 2026 | $52.64M USD | -6.2% | -11.5% | 19.6% | |
| Mar 2026 | $5.95M USD | -45.6% | -49.4% | 11.5% | |
| Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding MBOT) | — | -6.2% | -12.4% | 0.0% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.